Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
International Journal of Hematology
|
June 13, 2020
Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study
Takashi Ikeda, Shin-Ichiro Fujiwara, HIrotomo Nakajima, et al.
Leukemia & Lymphoma
|
February 14, 2022
Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation
Takashi Nagayama, Shin-Ichiro Fujiwara, Tomohiro Kikuchi, et al.
Blood Advances
|
November 8, 2019
Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation
Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, et al.
International Journal of Hematology
|
November 30, 2017
Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia
Shin-Ichiro Fujiwara, Yuya Shirato, Takashi Ikeda, et al.
British Journal of Haematology
|
January 20, 2023
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, et al.
Annals of Hematology
|
November 27, 2018
Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia
Kiyomi Mashima, Takashi Ikeda, Shin-Ichiro Kawaguchi, et al.
International Journal of Hematology
|
December 12, 2018
Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies
Daisuke Minakata, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Clinical Transplantation
|
April 6, 2024
Effects of CD34<sup>+</sup> cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation
Takashi Oyama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, et al.
Blood
|
May 17, 2022
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma
Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama, et al.
Transplantation and Cellular Therapy
|
October 6, 2023
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
International Journal of Hematology
|
June 13, 2020
Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study
Takashi Ikeda, Shin-Ichiro Fujiwara, HIrotomo Nakajima, et al.
Leukemia & Lymphoma
|
February 14, 2022
Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation
Takashi Nagayama, Shin-Ichiro Fujiwara, Tomohiro Kikuchi, et al.
Blood Advances
|
November 8, 2019
Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation
Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, et al.
International Journal of Hematology
|
November 30, 2017
Successful treatment of follicular lymphoma with second-generation tyrosine kinase inhibitors administered for coexisting chronic myeloid leukemia
Shin-Ichiro Fujiwara, Yuya Shirato, Takashi Ikeda, et al.
British Journal of Haematology
|
January 20, 2023
Relapsed and refractory multiple myeloma: A systematic review and network meta-analysis of the efficacy of novel therapies
Daisuke Minakata, Shin-Ichiro Fujiwara, Daizo Yokoyama, et al.
Annals of Hematology
|
November 27, 2018
Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia
Kiyomi Mashima, Takashi Ikeda, Shin-Ichiro Kawaguchi, et al.
International Journal of Hematology
|
December 12, 2018
Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies
Daisuke Minakata, Shin-Ichiro Fujiwara, Takashi Ikeda, et al.
Clinical Transplantation
|
April 6, 2024
Effects of CD34<sup>+</sup> cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation
Takashi Oyama, Shin-Ichiro Fujiwara, Ryutaro Tominaga, et al.
Blood
|
May 17, 2022
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma
Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama, et al.
Transplantation and Cellular Therapy
|
October 6, 2023
Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Chihiro Yamamoto, Daisuke Minakata, Daizo Yokoyama, et al.
Page
of 11